NCT02212951View on ClinicalTrials.gov

Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2014

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

BIOD-531

DRUG

Humalog Mix 75/25

DRUG

Humulin R U-500

Trial Locations (1)

Unknown

Profil Institute for Clinical Research, Chula Vista

Sponsors

Lead Sponsor

Biodel
All Listed Sponsors
lead

Biodel

INDUSTRY